Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Amanda Bronstad | June 15, 2017
Eli Lilly & Co. plans to move this month to dismiss a long-standing appeal in a case brought on behalf of a proposed class of consumers who used Cymbalta, an antidepressant prescription drug, according to a status report filed this week. The reason: Monday's decision by the U.S. Supreme Court in "Microsoft v. Baker," which blocked a controversial procedural tool that allowed plaintiffs to appeal class certification orders by dismissing their own case.
1 minute read
By ROBERT STORACE | June 14, 2017
An expert on DUI law in Connecticut, James O. Ruane has been an early adopter of the latest technology in defending Connecticut residents in DUI cases since 1988.
1 minute read
By Greg Land | June 14, 2017
A Dodge County pharmacy has agreed to pay $2.175 million to settle a Medicare false-billing case in what authorities in Georgia's Southern District say is their largest civil recovery ever under the Controlled Substances Act, as well as the largest pharmacy-related False Claims Act settlement in the district's history.
1 minute read
By Tony Mauro | June 14, 2017
Civil litigators and corporate counsel can almost taste victory in Bristol-Myers Squibb v. Superior Court of California, seen as the term's most important case on jurisdiction.
1 minute read
By Josefa Velasquez | June 13, 2017
The Republican-led Senate was poised to pass a package of more than a dozen bills aimed at curbing heroin and opioid abuse, including one that would set new limits on prescribing to minors.
1 minute read
By Amanda Bronstad | June 12, 2017
The first bellwether trial over a prescription medication used to treat low testosterone has ended in a mistrial after lead plaintiffs' attorney Christopher Seeger suffered from heart problems.
1 minute read
By Kristen Rasmussen | June 12, 2017
Last week, the U.S. Food and Drug Administration asked Endo Pharmaceuticals Inc. to remove Opana ER, its extended-release version of oxymorphone hydrochloride, from the market after the agency found a likelihood of abuse by crushing up and injecting the pills.
1 minute read
By Amanda Bronstad | June 12, 2017
On Monday, a jury came out with a defense verdict in the second trial over the blood thinner. That's about a month after Johnson & Johnson and Bayer won the first bellwether trial over Xarelto.
1 minute read
By Max Mitchell | June 9, 2017
The upcoming antitrust trial over Cephalon's alleged reverse-payment settlements with generic drug companies needs to be bifurcated at the liability phase, a federal judge has ruled.
1 minute read
By Jennifer Williams-Alvarez | June 9, 2017
For close to a decade, the Federal Trade Commission has been trying to get its hands on documents from drugmaker Boehringer Ingelheim Pharmaceuticals Inc., resulting in a yearslong dispute over what documents and communications are protected when an in-house counsel is involved.
1 minute read
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
East Brunswick Law firm concentrating in plaintiff's personal injury, employment law, medical malpractice and worker's compensation seeks an...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS